Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle
Clinical trial NCT02817464 · COMPLETED
Trial details
- NCT number
- NCT02817464
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-26
- Primary completion
- 2018-12-03
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.